Finally, the 4 main clusters were found significantly associated with disease-free survival (DFS) and OS in all patients, and in patients with early-stage HR+/HER2- breast cancer (Fig. 5e), and PFS in patients with advanced HR+/HER2- breast cancer in the MSKCC dataset (Supplemental Fig. 22b). Here, ERBB2 is linked to breast carcinoma.